Cargando…

2739. Evaluation of a Perioperative Fungal Prophylaxis Protocol Change in Orthotopic Liver Transplant

BACKGROUND: Orthotopic liver transplant (OLT) carries a high rate of fungal infections, including invasive fungal infections (IFI). A targeted antifungal prophylaxis protocol can identify OLT patients who warrant antifungal prophylaxis and optimize agent selection. In January 2021, a targeted antifu...

Descripción completa

Detalles Bibliográficos
Autores principales: Shulkosky, Megan, Xhemali, Xhilda, Eckardt, Jamie, Ward, Jessica, Schlick, Heather, Brizendine, Kyle D, Palm, Nicole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678184/
http://dx.doi.org/10.1093/ofid/ofad500.2350
_version_ 1785150302530306048
author Shulkosky, Megan
Xhemali, Xhilda
Eckardt, Jamie
Ward, Jessica
Schlick, Heather
Brizendine, Kyle D
Palm, Nicole
author_facet Shulkosky, Megan
Xhemali, Xhilda
Eckardt, Jamie
Ward, Jessica
Schlick, Heather
Brizendine, Kyle D
Palm, Nicole
author_sort Shulkosky, Megan
collection PubMed
description BACKGROUND: Orthotopic liver transplant (OLT) carries a high rate of fungal infections, including invasive fungal infections (IFI). A targeted antifungal prophylaxis protocol can identify OLT patients who warrant antifungal prophylaxis and optimize agent selection. In January 2021, a targeted antifungal prophylaxis post-liver transplant protocol was implemented at Cleveland Clinic. Since its introduction, rates of fungal infections and adherence to the protocol have not been assessed. The goal of this project is to describe the impact of a protocol change in OLT recipients. [Figure: see text] METHODS: This was a retrospective observational cohort study of patients ≥ 18 years old with an OLT +/- sequential kidney transplant at Cleveland Clinic. Review of perioperative fungal prophylaxis from June 1, 2019 – May 31, 2020 was performed and used as the baseline. The post-intervention period was June 1, 2021 – May 31, 2022. The primary objective was to determine adherence to the new OLT fungal prophylaxis protocol on post-operative day (POD) 0. Secondary objectives included the 90-day incidence of proven or probable IFI post-OLT before and after implementation. Study Population [Figure: see text] RESULTS: A total of 134 patients pre-protocol and 166 patients post-protocol were included. Prior to protocol implementation, 73% patients were prescribed clotrimazole, 13% fluconazole, 13% micafungin, and 1% nystatin. After protocol implementation, 63% were prescribed clotrimazole, 16% fluconazole, and 21% micafungin. In the post-protocol group, there was an adherence rate of 66% on POD0 which increased to 84% over the duration of prophylaxis. Prior to initiation of the antifungal protocol, 6.7% of patients developed an IFI while 3.6% of patients developed an IFI post-protocol (p=0.22). Median time to IFI was 8 days (IQR 2-19) pre-protocol and 15 days (IQR 6-17) post-protocol. Mortality and ICU length of stay were comparable between groups. Primary and Secondary Results [Figure: see text] OLT: orthotopic liver transplant; POD: post-operative day; ICU: intensive care unit; IFI: invasive fungal infection Characteristics of Patients with Invasive Fungal Infections [Figure: see text] IFI: invasive fungal infection; TPN: total parenteral nutrition; IAI: intra-abdominal infection; n/a: not applicable; pRBC: packed red blood cells; OR: operating room; RRT: renal replacement therapy; ICU: intensive care unit; Dose dep.: dose dependent; GI: gastrointestinal CONCLUSION: The implementation of a targeted antifungal prophylaxis post-liver transplant protocol can be a powerful strategy for promoting consistency in antifungal prophylaxis within a population at high risk for IFIs. Our study showed an 84% adherence rate to the implemented protocol, with numerically lower rates of IFIs post-protocol compared to pre-protocol. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-10678184
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106781842023-11-27 2739. Evaluation of a Perioperative Fungal Prophylaxis Protocol Change in Orthotopic Liver Transplant Shulkosky, Megan Xhemali, Xhilda Eckardt, Jamie Ward, Jessica Schlick, Heather Brizendine, Kyle D Palm, Nicole Open Forum Infect Dis Abstract BACKGROUND: Orthotopic liver transplant (OLT) carries a high rate of fungal infections, including invasive fungal infections (IFI). A targeted antifungal prophylaxis protocol can identify OLT patients who warrant antifungal prophylaxis and optimize agent selection. In January 2021, a targeted antifungal prophylaxis post-liver transplant protocol was implemented at Cleveland Clinic. Since its introduction, rates of fungal infections and adherence to the protocol have not been assessed. The goal of this project is to describe the impact of a protocol change in OLT recipients. [Figure: see text] METHODS: This was a retrospective observational cohort study of patients ≥ 18 years old with an OLT +/- sequential kidney transplant at Cleveland Clinic. Review of perioperative fungal prophylaxis from June 1, 2019 – May 31, 2020 was performed and used as the baseline. The post-intervention period was June 1, 2021 – May 31, 2022. The primary objective was to determine adherence to the new OLT fungal prophylaxis protocol on post-operative day (POD) 0. Secondary objectives included the 90-day incidence of proven or probable IFI post-OLT before and after implementation. Study Population [Figure: see text] RESULTS: A total of 134 patients pre-protocol and 166 patients post-protocol were included. Prior to protocol implementation, 73% patients were prescribed clotrimazole, 13% fluconazole, 13% micafungin, and 1% nystatin. After protocol implementation, 63% were prescribed clotrimazole, 16% fluconazole, and 21% micafungin. In the post-protocol group, there was an adherence rate of 66% on POD0 which increased to 84% over the duration of prophylaxis. Prior to initiation of the antifungal protocol, 6.7% of patients developed an IFI while 3.6% of patients developed an IFI post-protocol (p=0.22). Median time to IFI was 8 days (IQR 2-19) pre-protocol and 15 days (IQR 6-17) post-protocol. Mortality and ICU length of stay were comparable between groups. Primary and Secondary Results [Figure: see text] OLT: orthotopic liver transplant; POD: post-operative day; ICU: intensive care unit; IFI: invasive fungal infection Characteristics of Patients with Invasive Fungal Infections [Figure: see text] IFI: invasive fungal infection; TPN: total parenteral nutrition; IAI: intra-abdominal infection; n/a: not applicable; pRBC: packed red blood cells; OR: operating room; RRT: renal replacement therapy; ICU: intensive care unit; Dose dep.: dose dependent; GI: gastrointestinal CONCLUSION: The implementation of a targeted antifungal prophylaxis post-liver transplant protocol can be a powerful strategy for promoting consistency in antifungal prophylaxis within a population at high risk for IFIs. Our study showed an 84% adherence rate to the implemented protocol, with numerically lower rates of IFIs post-protocol compared to pre-protocol. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10678184/ http://dx.doi.org/10.1093/ofid/ofad500.2350 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Shulkosky, Megan
Xhemali, Xhilda
Eckardt, Jamie
Ward, Jessica
Schlick, Heather
Brizendine, Kyle D
Palm, Nicole
2739. Evaluation of a Perioperative Fungal Prophylaxis Protocol Change in Orthotopic Liver Transplant
title 2739. Evaluation of a Perioperative Fungal Prophylaxis Protocol Change in Orthotopic Liver Transplant
title_full 2739. Evaluation of a Perioperative Fungal Prophylaxis Protocol Change in Orthotopic Liver Transplant
title_fullStr 2739. Evaluation of a Perioperative Fungal Prophylaxis Protocol Change in Orthotopic Liver Transplant
title_full_unstemmed 2739. Evaluation of a Perioperative Fungal Prophylaxis Protocol Change in Orthotopic Liver Transplant
title_short 2739. Evaluation of a Perioperative Fungal Prophylaxis Protocol Change in Orthotopic Liver Transplant
title_sort 2739. evaluation of a perioperative fungal prophylaxis protocol change in orthotopic liver transplant
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678184/
http://dx.doi.org/10.1093/ofid/ofad500.2350
work_keys_str_mv AT shulkoskymegan 2739evaluationofaperioperativefungalprophylaxisprotocolchangeinorthotopiclivertransplant
AT xhemalixhilda 2739evaluationofaperioperativefungalprophylaxisprotocolchangeinorthotopiclivertransplant
AT eckardtjamie 2739evaluationofaperioperativefungalprophylaxisprotocolchangeinorthotopiclivertransplant
AT wardjessica 2739evaluationofaperioperativefungalprophylaxisprotocolchangeinorthotopiclivertransplant
AT schlickheather 2739evaluationofaperioperativefungalprophylaxisprotocolchangeinorthotopiclivertransplant
AT brizendinekyled 2739evaluationofaperioperativefungalprophylaxisprotocolchangeinorthotopiclivertransplant
AT palmnicole 2739evaluationofaperioperativefungalprophylaxisprotocolchangeinorthotopiclivertransplant